ICU

SeaStar Medical (ICU)

SeaStar Medical Holding Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ICU

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/07/26	22:00	GlobeNewswire Inc.	Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/07/23	21:30	GlobeNewswire Inc.	First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/07/17	22:00	GlobeNewswire Inc.	Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/07/16	21:30	GlobeNewswire Inc.	CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/07/13	06:05	PR Newswire (US)	ICU SHAREHOLDER ALERT: Edelson Lechtzin LLP Urges SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW) Shareholders to Consult Legal Counsel About the Pending Securities Fraud Class Action	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/07/12	21:30	GlobeNewswire Inc.	SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/07/12	05:05	GlobeNewswire Inc.	SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/07/10	22:00	GlobeNewswire Inc.	SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/07/03	21:30	GlobeNewswire Inc.	SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/06/11	21:30	GlobeNewswire Inc.	SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/06/10	21:30	GlobeNewswire Inc.	SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/06/07	21:30	GlobeNewswire Inc.	Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/06/06	21:30	GlobeNewswire Inc.	SeaStar Medical Announces 25-for-1 Reverse Stock Split	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/05/22	21:30	GlobeNewswire Inc.	Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/05/15	05:05	GlobeNewswire Inc.	SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/04/30	21:30	GlobeNewswire Inc.	SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/04/18	05:00	GlobeNewswire Inc.	SeaStar Medical Reports 2023 Financial Results and Provides a Business Update	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/04/11	21:30	GlobeNewswire Inc.	SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/03/27	21:30	GlobeNewswire Inc.	SeaStar Medical to Restate Financials, Sets Business Update Call for April 17	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/03/12	21:30	GlobeNewswire Inc.	SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/03/12	05:05	GlobeNewswire Inc.	SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/02/27	22:30	GlobeNewswire Inc.	Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/02/22	21:58	GlobeNewswire Inc.	Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/02/22	21:53	GlobeNewswire Inc.	FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/02/01	22:30	GlobeNewswire Inc.	SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/01/26	22:05	GlobeNewswire Inc.	SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/01/12	06:05	GlobeNewswire Inc.	SeaStar Medical Appoints David A. Green as Chief Financial Officer	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/01/09	22:30	GlobeNewswire Inc.	SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/12/28	22:30	GlobeNewswire Inc.	SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/12/13	22:30	GlobeNewswire Inc.	SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical Experts	NASDAQ:ICU	SeaStar Medical Holding Corporation